NCT02482194View on ClinicalTrials.gov

Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Spinal Cord Injury
Interventions
BIOLOGICAL

mesenchymal stem cells

autologous transplantation of mesenchymal stem cells in spinal cord injury patients

Trial Locations (1)

46000

Armed Forces Bone Marrow Transplant Centre, Rawalpindi

All Listed Sponsors
collaborator

Armed Forces Institute of Regenerative Medicine

FED

lead

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

OTHER_GOV

NCT02482194 - Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study | Biotech Hunter | Biotech Hunter